Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2226)
All Articles published online
|
Feb 14, 2008 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhou J, Wang CY, Liu T, Wu B, Zhou F, Xiong JX, Wu HS, Tao J, Zhao G, Yang M, Gou SM. Persistence of side population cells with high drug efflux capacity in pancreatic cancer. World J Gastroenterol 2008; 14(6): 925-930 [PMID: 18240351 DOI: 10.3748/wjg.14.925] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i6/925.htm |
| Number | Citing Articles |
| 1 |
Yifan Qian, Yang Xiong, Di Feng, Yali Wu, Xu Zhang, Liping Chen, Mancang Gu. Coix Seed Extract Enhances the Anti-Pancreatic Cancer Efficacy of Gemcitabine through Regulating ABCB1- and ABCG2-Mediated Drug Efflux: A Bioluminescent Pharmacokinetic and Pharmacodynamic Study. International Journal of Molecular Sciences 2019; 20(21): 5250 doi: 10.3390/ijms20215250
|
| 2 |
RUI-RUI ZHENG, WEI HU, CHENG-GUANG SUI, NAN MA, YOU-HONG JIANG. Effects of doxorubicin and gemcitabine on the induction of apoptosis in breast cancer cells. Oncology Reports 2014; 32(6): 2719 doi: 10.3892/or.2014.3513
|
| 3 |
Gregory Sergeant, Hugo Vankelecom, Lies Gremeaux, Baki Topal. Role of cancer stem cells in pancreatic ductal adenocarcinoma. Nature Reviews Clinical Oncology 2009; 6(10): 580 doi: 10.1038/nrclinonc.2009.127
|
| 4 |
Evelyn Winter, Patrícia Devantier Neuenfeldt, Louise Domeneghini Chiaradia-Delatorre, Charlotte Gauthier, Rosendo Augusto Yunes, Ricardo José Nunes, Tânia Beatriz Creczynski-Pasa, Attilio Di Pietro. Symmetric Bis-chalcones as a New Type of Breast Cancer Resistance Protein Inhibitors with a Mechanism Different from That of Chromones. Journal of Medicinal Chemistry 2014; 57(7): 2930 doi: 10.1021/jm401879z
|
| 5 |
Murielle Mimeault, Surinder K. Batra. Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies. Molecular Aspects of Medicine 2014; 39: 3 doi: 10.1016/j.mam.2013.08.001
|
| 6 |
Bradley T. Williamson, Heather A. Leitch. Higher Risk Myelodysplastic Syndromes in Patients with Well-Controlled HIV Infection: Clinical Features, Treatment, and Outcome. Case Reports in Hematology 2016; 2016: 1 doi: 10.1155/2016/8502641
|
| 7 |
Yuuki Shichi, Fujiya Gomi, Norihiko Sasaki, Keisuke Nonaka, Tomio Arai, Toshiyuki Ishiwata. Epithelial and Mesenchymal Features of Pancreatic Ductal Adenocarcinoma Cell Lines in Two- and Three-Dimensional Cultures. Journal of Personalized Medicine 2022; 12(5): 746 doi: 10.3390/jpm12050746
|
| 8 |
Charudatt Samant, Ramesh Kale, K. Sreedhara Ranganath Pai, Krishnadas Nandakumar, Mandar Bhonde. Role of Wnt/β-catenin pathway in cancer drug resistance: Insights into molecular aspects of major solid tumors. Biochemical and Biophysical Research Communications 2024; 729: 150348 doi: 10.1016/j.bbrc.2024.150348
|
| 9 |
I. Ischenko, A. Renner, H. Seeliger, A. Kleespies, J. W. Ellwart, P. Camaj, M. E. Eichhorn, K. -W. Jauch, C. J. Bruns. Chirurgisches Forum und DGAV Forum 2009. Deutsche Gesellschaft für Chirurgie 2009; 38: 55 doi: 10.1007/978-3-642-00625-8_22
|
| 10 |
Abhijeet Deshmukh, Kedar Deshpande, Frank Arfuso, Philip Newsholme, Arun Dharmarajan. Cancer stem cell metabolism: a potential target for cancer therapy. Molecular Cancer 2016; 15(1) doi: 10.1186/s12943-016-0555-x
|
| 11 |
Atsushi Okamoto, Kazuaki Chikamatsu, Koichi Sakakura, Kyosuke Hatsushika, Goro Takahashi, Keisuke Masuyama. Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck. Oral Oncology 2009; 45(7): 633 doi: 10.1016/j.oraloncology.2008.10.003
|
| 12 |
Lisa Y. Pang, Alejandro Cervantes-Arias, Rod W. Else, David J. Argyle. Canine Mammary Cancer Stem Cells are Radio- and Chemo- Resistant and Exhibit an Epithelial-Mesenchymal Transition Phenotype. Cancers 2011; 3(2): 1744 doi: 10.3390/cancers3021744
|
| 13 |
Min Xu, Lei Li, Zhiqiang Liu, Zhijun Jiao, Ping Xu, Xiangyu Kong, Haojie Huang, Youli Zhang. ABCB2 (TAP1) as the downstream target of SHH signaling enhances pancreatic ductal adenocarcinoma drug resistance. Cancer Letters 2013; 333(2): 152 doi: 10.1016/j.canlet.2013.01.002
|
| 14 |
Yue Zhao, Lu Zhao, Ivan Ischenko, Qi Bao, Bettina Schwarz, Hanno Nieß, Yan Wang, Andrea Renner, Josef Mysliwietz, Karl-Walter Jauch, Peter J. Nelson, Joachim W. Ellwart, Christiane J. Bruns, Peter Camaj. Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer. Targeted Oncology 2015; 10(4): 535 doi: 10.1007/s11523-015-0360-2
|
| 15 |
Anke Van den broeck, Hugo Vankelecom, Wouter Van Delm, Lies Gremeaux, Jasper Wouters, Joke Allemeersch, Olivier Govaere, Tania Roskams, Baki Topal, Irina V. Lebedeva. Human Pancreatic Cancer Contains a Side Population Expressing Cancer Stem Cell-Associated and Prognostic Genes. PLoS ONE 2013; 8(9): e73968 doi: 10.1371/journal.pone.0073968
|
| 16 |
Murielle Mimeault, Surinder K. Batra. Molecular Biomarkers of Cancer Stem/Progenitor Cells Associated with Progression, Metastases, and Treatment Resistance of Aggressive Cancers. Cancer Epidemiology, Biomarkers & Prevention 2014; 23(2): 234 doi: 10.1158/1055-9965.EPI-13-0785
|
| 17 |
Bauer L. LeSavage, Daiyao Zhang, Carla Huerta-López, Aidan E. Gilchrist, Brad A. Krajina, Kasper Karlsson, Amber R. Smith, Kremena Karagyozova, Katarina C. Klett, Michelle S. Huang, Christopher Long, Gernot Kaber, Christopher M. Madl, Paul L. Bollyky, Christina Curtis, Calvin J. Kuo, Sarah C. Heilshorn. Engineered matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids. Nature Materials 2024; 23(8): 1138 doi: 10.1038/s41563-024-01908-x
|
| 18 |
Vikash J. Bhagwandin, Jerry W. Shay. Pancreatic cancer stem cells: Fact or fiction?. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2009; 1792(4): 248 doi: 10.1016/j.bbadis.2009.02.007
|
| 19 |
Stephanie Ma, Kwok Wah Chan, Xin-Yuan Guan. In Search of Liver Cancer Stem Cells. Stem Cell Reviews 2008; 4(3): 179 doi: 10.1007/s12015-008-9035-z
|
| 20 |
Ivan Ischenko, Hendrik Seeliger, Axel Kleespies, Martin K. Angele, Martin E. Eichhorn, Karl-Walter Jauch, Christiane J. Bruns. Pancreatic cancer stem cells: new understanding of tumorigenesis, clinical implications. Langenbeck's Archives of Surgery 2010; 395(1): 1 doi: 10.1007/s00423-009-0502-z
|
| 21 |
Karobi Moitra. Overcoming Multidrug Resistance in Cancer Stem Cells. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/635745
|
| 22 |
Murielle Mimeault, Surinder K. Batra. Signal Transduction in Cancer Metastasis. Cancer Metastasis - Biology and Treatment 2010; 15: 175 doi: 10.1007/978-90-481-9522-0_10
|
| 23 |
Hanno Niess, Peter Camaj, Andrea Renner, Ivan Ischenko, Yue Zhao, Stefan Krebs, Josef Mysliwietz, Carsten Jäckel, Peter J. Nelson, Helmut Blum, Karl-Walter Jauch, Joachim W. Ellwart, Christiane J. Bruns. Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis. Targeted Oncology 2015; 10(2): 215 doi: 10.1007/s11523-014-0323-z
|
| 24 |
Rachit Kumar, Avani Dholakia, Zeshaan Rasheed. Stem cell–directed therapies in pancreatic cancer. Current Problems in Cancer 2013; 37(5): 280 doi: 10.1016/j.currproblcancer.2013.10.005
|
| 25 |
Jian-Lin Wang, Jing-Ping Yu, Zhi-Qiang Sun, Su-Ping Sun. Radiobiological characteristics of cancer stem cells from esophageal cancer cell lines. World Journal of Gastroenterology 2014; 20(48): 18296-18305 doi: 10.3748/wjg.v20.i48.18296
|
| 26 |
D D Fang, Y J Kim, C N Lee, S Aggarwal, K McKinnon, D Mesmer, J Norton, C E Birse, T He, S M Ruben, P A Moore. Expansion of CD133+ colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. British Journal of Cancer 2010; 102(8): 1265 doi: 10.1038/sj.bjc.6605610
|
| 27 |
Jasper Wouters, Hugo Vankelecom, Joost van den Oord. Cancer stem cells in cutaneous melanoma. Expert Review of Dermatology 2009; 4(3): 225 doi: 10.1586/edm.09.17
|
| 28 |
Irene Miranda-Lorenzo, Jorge Dorado, Enza Lonardo, Sonia Alcala, Alicia G Serrano, Jenifer Clausell-Tormos, Michele Cioffi, Diego Megias, Sladjana Zagorac, Anamaria Balic, Manuel Hidalgo, Mert Erkan, Joerg Kleeff, Aldo Scarpa, Bruno Sainz, Christopher Heeschen. Intracellular autofluorescence: a biomarker for epithelial cancer stem cells. Nature Methods 2014; 11(11): 1161 doi: 10.1038/nmeth.3112
|
| 29 |
M.A. González-Moles, C. Scully, I. Ruiz-Ávila, J.J. Plaza-Campillo. The cancer stem cell hypothesis applied to oral carcinoma. Oral Oncology 2013; 49(8): 738 doi: 10.1016/j.oraloncology.2013.04.002
|
| 30 |
Yue Sun, Mancang Gu, Lixin Zhu, Junying Liu, Yang Xiong, Yinghui Wei, Fanzhu Li. Gemcitabine upregulates ABCG2/BCRP and modulates the intracellular pharmacokinetic profiles of bioluminescence in pancreatic cancer cells. Anti-Cancer Drugs 2016; 27(3): 183 doi: 10.1097/CAD.0000000000000315
|
| 31 |
Kyle McIntosh, Curt Balch, Amit K. Tiwari. Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells. Expert Opinion on Drug Metabolism & Toxicology 2016; 12(6): 633 doi: 10.1080/17425255.2016.1179280
|
| 32 |
Vinitha Richard, Madhumathy G. Nair, T. R. Santhosh Kumar, M. Radhakrishna Pillai. Side Population Cells as Prototype of Chemoresistant, Tumor-Initiating Cells. BioMed Research International 2013; 2013: 1 doi: 10.1155/2013/517237
|
| 33 |
Nicolas Jonckheere, Nicolas Skrypek, Isabelle Van Seuningen. Mucins and tumor resistance to chemotherapeutic drugs. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2014; 1846(1): 142 doi: 10.1016/j.bbcan.2014.04.008
|
| 34 |
Satoshi Matsukuma, Kiyoshi Yoshimura, Tomio Ueno, Atsunori Oga, Moeko Inoue, Yusaku Watanabe, Atsuo Kuramasu, Masanori Fuse, Ryouichi Tsunedomi, Satoshi Nagaoka, Hidetoshi Eguchi, Hiroto Matsui, Yoshitaro Shindo, Noriko Maeda, Yoshihiro Tokuhisa, Reo Kawano, Tomoko Furuya‐Kondo, Hiroshi Itoh, Shigefumi Yoshino, Shoichi Hazama, Masaaki Oka, Hiroaki Nagano. Calreticulin is highly expressed in pancreatic cancer stem‐like cells. Cancer Science 2016; 107(11): 1599 doi: 10.1111/cas.13061
|
| 35 |
Madhurima Das, Sujata Law. Role of tumor microenvironment in cancer stem cell chemoresistance and recurrence. The International Journal of Biochemistry & Cell Biology 2018; 103: 115 doi: 10.1016/j.biocel.2018.08.011
|
| 36 |
Hiroki Fukuchi, Yukinobu Hayashida, Kunio Inoue, Yoshifusa Sadamura. Forkhead box B2 inhibits the malignant characteristics of the pancreatic cancer cell line Panc‐1 in vitro. Genes to Cells 2019; 24(10): 674 doi: 10.1111/gtc.12717
|
| 37 |
Anke Van den broeck, Lies Gremeaux, Baki Topal, Hugo Vankelecom. Human pancreatic adenocarcinoma contains a side population resistant to gemcitabine. BMC Cancer 2012; 12(1) doi: 10.1186/1471-2407-12-354
|
| 38 |
Marina Gergues, Vibha Harindra Savanur, David Prado, Adam Eljarrah, James K. Liu, Mohammed Jaloudi, Pranela Rameshwar. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies. 2021; : 507 doi: 10.1016/B978-0-12-821567-8.00012-9
|
| 39 |
Alice Nomura, Olivia McGinn, Vikas Dudeja, Veena Sangwan, Ashok K. Saluja, Sulagna Banerjee. Minnelide effectively eliminates CD133+ side population in pancreatic cancer. Molecular Cancer 2015; 14(1) doi: 10.1186/s12943-015-0470-6
|
| 40 |
Murielle Mimeault, Surinder K. Batra. Stem Cell Biology in Health and Disease. 2009; : 385 doi: 10.1007/978-90-481-3040-5_17
|
| 41 |
An-Mei Zhang, Ye Fan, Quan Yao, Hu Ma, Sheng Lin, Cong-Hui Zhu, Xin-Xin Wang, Jia Liu, Bo Zhu, Jian-Guo Sun, Zheng-Tang Chen. Identification of a Cancer Stem-like Population in the Lewis Lung Cancer Cell Line. Asian Pacific Journal of Cancer Prevention 2012; 13(3): 761 doi: 10.7314/APJCP.2012.13.3.761
|
| 42 |
William Telford. Applications of Flow Cytometry in Stem Cell Research and Tissue Regeneration. 2010; : 25 doi: 10.1002/9780470631119.ch3
|
| 43 |
Yutong Zhao, Cheng Qin, Bangbo Zhao, Yuanyang Wang, Zeru Li, Tianyu Li, Xiaoying Yang, Weibin Wang. Pancreatic cancer stemness: dynamic status in malignant progression. Journal of Experimental & Clinical Cancer Research 2023; 42(1) doi: 10.1186/s13046-023-02693-2
|
| 44 |
Inamul Haque, Archana De, Monami Majumder, Smita Mehta, Douglas McGregor, Sushanta K. Banerjee, Peter Van Veldhuizen, Snigdha Banerjee. The Matricellular Protein CCN1/Cyr61 Is a Critical Regulator of Sonic Hedgehog in Pancreatic Carcinogenesis. Journal of Biological Chemistry 2012; 287(46): 38569 doi: 10.1074/jbc.M112.389064
|
| 45 |
Ulrike Olszewski, Richard Liedauer, Christoph Ausch, Theresia Thalhammer, Gerhard Hamilton. Overexpression of CYP3A4 in a COLO 205 Colon Cancer Stem Cell Model in vitro. Cancers 2011; 3(1): 1467 doi: 10.3390/cancers3011467
|
| 46 |
Lie Yao, Jichun Gu, Yishen Mao, Xinju Zhang, Xiaoyi Wang, Chen Jin, Deliang Fu, Ji Li. Dynamic quantitative detection of ABC transporter family promoter methylation by MS‑HRM for predicting MDR in pancreatic cancer. Oncology Letters 2018; doi: 10.3892/ol.2018.8041
|
| 47 |
KARL QUINT, MANUEL TONIGOLD, PIETRO DI FAZIO, ROBERTA MONTALBANO, SUSANNE LINGELBACH, FELIX RÜCKERT, BEATE ALINGER, MATTHIAS OCKER, DANIEL NEUREITER. Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition. International Journal of Oncology 2012; 41(6): 2093 doi: 10.3892/ijo.2012.1648
|
| 48 |
Romana-Rea Begicevic, Marco Falasca. ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance. International Journal of Molecular Sciences 2017; 18(11): 2362 doi: 10.3390/ijms18112362
|
| 49 |
Kshama R. Jaiswal, Hong-Wu Xin, Andrew Anderson, Gordon Wiegand, Bo Kim, Tyler Miller, Danielle Hari, Satyajit Ray, Tomotake Koizumi, Udo Rudloff, Snorri S. Thorgeirsson, Itzhak Avital. Comparative testing of various pancreatic cancer stem cells results in a novel class of pancreatic-cancer-initiating cells. Stem Cell Research 2012; 9(3): 249 doi: 10.1016/j.scr.2012.08.001
|
| 50 |
Jorge Melendez-Zajgla, Vilma Maldonado. The Role of lncRNAs in the Stem Phenotype of Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2021; 22(12): 6374 doi: 10.3390/ijms22126374
|
| 51 |
Miriam López-Gómez, Enrique Casado, Marta Muñoz, Sonia Alcalá, Juan Moreno-Rubio, Gabriele D’Errico, Ana María Jiménez-Gordo, Silvia Salinas, Bruno Sainz. Current evidence for cancer stem cells in gastrointestinal tumors and future research perspectives. Critical Reviews in Oncology/Hematology 2016; 107: 54 doi: 10.1016/j.critrevonc.2016.08.006
|
| 52 |
Yu‐Ting Kao, Wei‐Chi Hsu, Huei‐Ting Hu, Shih‐Hsien Hsu, Chang‐Shen Lin, Chien‐Chih Chiu, Chi‐Yu Lu, Tzyh‐Chyuan Hour, Yeong‐Shiau Pu, A‐Mei Huang. Involvement of p38 mitogen‐activated protein kinase in acquired gemcitabine‐resistant human urothelial carcinoma sublines. The Kaohsiung Journal of Medical Sciences 2014; 30(7): 323 doi: 10.1016/j.kjms.2014.03.004
|
| 53 |
Toshiyuki Ishiwata, Yoko Matsuda, Hisashi Yoshimura, Norihiko Sasaki, Shunji Ishiwata, Naoshi Ishikawa, Kaiyo Takubo, Tomio Arai, Junko Aida. Pancreatic cancer stem cells: features and detection methods. Pathology & Oncology Research 2018; 24(4): 797 doi: 10.1007/s12253-018-0420-x
|
| 54 |
Jan Skoda, Karolina Borankova, Patric J. Jansson, Michael L.-H. Huang, Renata Veselska, Des R. Richardson. Pharmacological targeting of mitochondria in cancer stem cells: An ancient organelle at the crossroad of novel anti-cancer therapies. Pharmacological Research 2019; 139: 298 doi: 10.1016/j.phrs.2018.11.020
|
| 55 |
|
| 56 |
Asaad Azarnezhad, Parvin Mehdipour. Cancer Genetics and Psychotherapy. 2017; : 79 doi: 10.1007/978-3-319-64550-6_5
|
| 57 |
Taranjit S. Gujral, Marc W. Kirschner. Hippo pathway mediates resistance to cytotoxic drugs. Proceedings of the National Academy of Sciences 2017; 114(18) doi: 10.1073/pnas.1703096114
|
| 58 |
Zhen-Da Wang, Xi Tian, Yue Wang, Jun-Jie Wang, Shi-Qi Ye, Yong-Qiang Huang, Yuan-Yuan Qu, Kun Chang, Guo-Hai Shi, Ding-Wei Ye, Cheng-Yuan Gu. The expression and prognostic value of transporter 1, ATP binding cassette subfamily B member in clear cell renal cell cancer with experimental validation. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1013790
|
| 59 |
Souichi Yanamoto, Goro Kawasaki, Shin-ichi Yamada, Izumi Yoshitomi, Toshihiro Kawano, Hisanobu Yonezawa, Satoshi Rokutanda, Tomofumi Naruse, Masahiro Umeda. Isolation and characterization of cancer stem-like side population cells in human oral cancer cells. Oral Oncology 2011; 47(9): 855 doi: 10.1016/j.oraloncology.2011.06.501
|
| 60 |
Zhengyan Xu, Yanjun Jia, Xiaoxi Huang, Nianhua Feng, Ying Li. Rapid induction of pancreatic cancer cells to cancer stem cells via heterochromatin modulation. Cell Cycle 2018; 17(12): 1487 doi: 10.1080/15384101.2018.1489180
|
| 61 |
Ivan Ischenko, Hendrik Seeliger, Karl-Walter Jauch, Christiane J. Bruns. Metastatic activity and chemotherapy resistance in human pancreatic cancer—influence of cancer stem cells. Surgery 2009; 146(3): 430 doi: 10.1016/j.surg.2009.05.003
|
| 62 |
Guan-Nan Zhang, Yi Liang, Ling-Jun Zhou, Shu-Peng Chen, Ge Chen, Tai-Ping Zhang, Tiebang Kang, Yu-Pei Zhao. Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells. Cancer Letters 2011; 313(2): 137 doi: 10.1016/j.canlet.2011.05.030
|
| 63 |
Yue Zhao, Qi Bao, Bettina Schwarz, Lu Zhao, Josef Mysliwietz, Joachim Ellwart, Andera Renner, Heidrun Hirner, Hanno Niess, Peter Camaj, Martin Angele, Stephanie Gros, Jakob Izbicki, Karl-Walter Jauch, Peter Jon Nelson, Christiane J. Bruns. Stem Cell-Like Side Populations in Esophageal Cancer: A Source of Chemotherapy Resistance and Metastases. Stem Cells and Development 2014; 23(2): 180 doi: 10.1089/scd.2013.0103
|
| 64 |
Jorge Dorado, Alicia G. Serrano, Christopher Heeschen. Cancer Stem Cells in Solid Tumors. 2011; : 79 doi: 10.1007/978-1-61779-246-5_5
|
| 65 |
Qi Bao, Yue Zhao, Andrea Renner, Hanno Niess, Hendrik Seeliger, Karl-Walter Jauch, Christiane J. Bruns. Cancer Stem Cells in Pancreatic Cancer. Cancers 2010; 2(3): 1629 doi: 10.3390/cancers2031629
|
| 66 |
Gang‐Ming Zou. Cancer initiating cells or cancer stem cells in the gastrointestinal tract and liver. Journal of Cellular Physiology 2008; 217(3): 598 doi: 10.1002/jcp.21541
|
| 67 |
Jessica A. Shafer, Conrad R. Cruz, Ann M. Leen, Stephanie Ku, An Lu, Alexandra Rousseau, Helen E. Heslop, Cliona M. Rooney, Catherine M. Bollard, Aaron E. Foster. Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma. Leukemia & Lymphoma 2010; 51(5): 870 doi: 10.3109/10428191003713968
|
| 68 |
Zhongbo Zhang, Yuanhong Xu, Chenghai Zhao. Fzd7/Wnt7b signaling contributes to stemness and chemoresistance in pancreatic cancer. Cancer Medicine 2021; 10(10): 3332 doi: 10.1002/cam4.3819
|
| 69 |
Elodie du Potet, Lauren Cameron, Nagy A. Habib, Natasa Levicar. Stem Cells & Regenerative Medicine. Stem Cell Biology and Regenerative Medicine 2011; : 59 doi: 10.1007/978-1-60761-860-7_4
|
| 70 |
Alessandro Allegra, Andrea Alonci, Giuseppa Penna, Vanessa Innao, Demetrio Gerace, Francesco Rotondo, Caterina Musolino. The Cancer Stem Cell Hypothesis: A Guide to Potential Molecular Targets. Cancer Investigation 2014; 32(9): 470 doi: 10.3109/07357907.2014.958231
|
| 71 |
LU ZHAO, YUE ZHAO, BETTINA SCHWARZ, JOSEF MYSLIWIETZ, ROLAND HARTIG, PETER CAMAJ, QI BAO, KARL-WALTER JAUCH, MAKUS GUBA, JOACHIM WALTER ELLWART, PETER JON NELSON, CHRISTIANE JOSEPHINE BRUNS. Verapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells. International Journal of Oncology 2016; 49(1): 99 doi: 10.3892/ijo.2016.3512
|
| 72 |
Murielle Mimeault, Surinder K. Batra. Recent insights into the molecular mechanisms involved in aging and the malignant transformation of adult stem/progenitor cells and their therapeutic implications. Ageing Research Reviews 2009; 8(2): 94 doi: 10.1016/j.arr.2008.12.001
|
| 73 |
Saravanakumar Marimuthu, Sanchita Rauth, Koelina Ganguly, Chunmeng Zhang, Imayavaramban Lakshmanan, Surinder K. Batra, Moorthy P. Ponnusamy. Mucins reprogram stemness, metabolism and promote chemoresistance during cancer progression. Cancer and Metastasis Reviews 2021; 40(2): 575 doi: 10.1007/s10555-021-09959-1
|
| 74 |
Lulu Farhana, Marcia I. Dawson, Jayanta K. Das, Farhan Murshed, Zebin Xia, Timothy J. Hadden, James Hatfield, Joseph A. Fontana. Adamantyl Retinoid-Related Molecules Induce Apoptosis in Pancreatic Cancer Cells by Inhibiting IGF-1R and Wnt/β-Catenin Pathways. Journal of Oncology 2012; 2012: 1 doi: 10.1155/2012/796729
|
| 75 |
Vikash J. Bhagwandin, J. Michael Bishop, Woodring E. Wright, Jerry W. Shay, Surinder K. Batra. The Metastatic Potential and Chemoresistance of Human Pancreatic Cancer Stem Cells. PLOS ONE 2016; 11(2): e0148807 doi: 10.1371/journal.pone.0148807
|
| 76 |
Maisie Lo, Ming-Sound Tsao, David Hedley, Victor Ling. Gene Expression Profiling of Adenosine Triphosphate-Binding Cassette Transporters in Response to K-ras Activation and Hypoxia in Human Pancreatic Cancer Cell Cultures. Pancreas 2009; 38(1): 85 doi: 10.1097/MPA.0b013e318184aa8a
|
| 77 |
Chih-Yen Chien, Hui-Ching Chuang, Chang-Han Chen. The side population of cancer stem-like cells in human oral cancer. Oral Oncology 2012; 48(10): 913 doi: 10.1016/j.oraloncology.2012.04.010
|
| 78 |
Hamed Gilzad Kohan, Mehdi Boroujerdi. Time and concentration dependency of P-gp, MRP1 and MRP5 induction in response to gemcitabine uptake in Capan-2 pancreatic cancer cells. Xenobiotica 2015; 45(7): 642 doi: 10.3109/00498254.2014.1001809
|
| 79 |
Ming-Chuan Hsu, Mei-Ren Pan, Pei-Yi Chu, Ya-Li Tsai, Chia-Hua Tsai, Yan-Shen Shan, Li-Tzong Chen, Wen-Chun Hung. Protein Arginine Methyltransferase 3 Enhances Chemoresistance in Pancreatic Cancer by Methylating hnRNPA1 to Increase ABCG2 Expression. Cancers 2018; 11(1): 8 doi: 10.3390/cancers11010008
|
| 80 |
Catherine Burkhart, Daria Fleyshman, Rachael Kohrn, Mairead Commane, Jennifer Garrigan, Vadim Kurbatov, Ilya Toshkov, Rajesh Ramachandran, Laura Martello, Katerina V. Gurova. Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer. Oncotarget 2014; 5(22): 11038 doi: 10.18632/oncotarget.2701
|
| 81 |
Henriette E. Meyer zu Schwabedissen, Heyo K. Kroemer. Drug Transporters. Handbook of Experimental Pharmacology 2011; 201: 325 doi: 10.1007/978-3-642-14541-4_9
|
| 82 |
Patricia Sancho, Sonia Alcala, Valentyn Usachov, Patrick C. Hermann, Bruno Sainz. The ever-changing landscape of pancreatic cancer stem cells. Pancreatology 2016; 16(4): 489 doi: 10.1016/j.pan.2016.04.004
|
| 83 |
Murielle Mimeault, Sonny L. Johansson, Shantibhusan Senapati, Navneet Momi, Subhankar Chakraborty, Surinder K. Batra. MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies. Cancer Letters 2010; 295(1): 69 doi: 10.1016/j.canlet.2010.02.015
|
| 84 |
H. S. Colvin, N. Nishida, J. Koseki, M. Konno, K. Kawamoto, K. Tsunekuni, Y. Doki, M. Mori, H. Ishii. Cancer Stem Cells of the Digestive System. Japanese Journal of Clinical Oncology 2014; 44(12): 1141 doi: 10.1093/jjco/hyu146
|
| 85 |
BINGHONG XIONG, LI MA, XIANG HU, CAIQUAN ZHANG, YONG CHENG. Characterization of side population cells isolated from the colon cancer cell line SW480. International Journal of Oncology 2014; 45(3): 1175 doi: 10.3892/ijo.2014.2498
|
| 86 |
Qiong Wu, Soni Sharma, Hang Cui, Scott E. LeBlanc, Hong Zhang, Rohini Muthuswami, Jeffrey A. Nickerson, Anthony N. Imbalzano. Targeting the chromatin remodeling enzyme BRG1 increases the efficacy of chemotherapy drugs in breast cancer cells. Oncotarget 2016; 7(19): 27158 doi: 10.18632/oncotarget.8384
|
| 87 |
K Moitra, H Lou, M Dean. Multidrug Efflux Pumps and Cancer Stem Cells: Insights Into Multidrug Resistance and Therapeutic Development. Clinical Pharmacology & Therapeutics 2011; 89(4): 491 doi: 10.1038/clpt.2011.14
|
| 88 |
Natalia Lipinska, Aleksandra Romaniuk, Anna Paszel-Jaworska, Ewa Toton, Przemyslaw Kopczynski, Blazej Rubis. Telomerase and drug resistance in cancer. Cellular and Molecular Life Sciences 2017; 74(22): 4121 doi: 10.1007/s00018-017-2573-2
|